EntryPoint Capital’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,438	Closed	-$46.6K	–	906
2024 Q3	$46.6K	Buy	+27,438	New	+$46.6K	0.03%	589
2024 Q2	–	Sell	-2,713	Closed	-$10.2K	–	1427
2024 Q1	$10.2K	Buy	+2,713	New	+$10.2K	0.01%	1234